Novartis Dividends and Buybacks
Dividend criteria checks 5/6
Novartis is a dividend paying company with a current yield of 3.48% that is well covered by earnings.
Key information
3.5%
Dividend yield
3.3%
Buyback Yield
| Total Shareholder Yield | 6.8% |
| Future Dividend Yield | 4.0% |
| Dividend Growth | 1.8% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | CHF 3.300 |
| Payout ratio | 68% |
Recent dividend and buyback updates
No updates
Recent updates
Stability and Growth of Payments
Fetching dividends data
Stable Dividend: NOVNEE's dividends per share have been stable in the past 10 years.
Growing Dividend: NOVNEE's dividend payments have increased over the past 10 years.
Dividend Yield vs Market
| Novartis Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (NOVNEE) | 3.5% |
| Market Bottom 25% (CH) | 2.0% |
| Market Top 25% (CH) | 4.4% |
| Industry Average (Pharmaceuticals) | 2.6% |
| Analyst forecast (NOVNEE) (up to 3 years) | 4.0% |
Notable Dividend: NOVNEE's dividend (3.48%) is higher than the bottom 25% of dividend payers in the Swiss market (2.02%).
High Dividend: NOVNEE's dividend (3.48%) is low compared to the top 25% of dividend payers in the Swiss market (4.45%).
Earnings Payout to Shareholders
Earnings Coverage: With its reasonable payout ratio (67.8%), NOVNEE's dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its reasonable cash payout ratio (57.2%), NOVNEE's dividend payments are covered by cash flows.